SUBURBAN LUNG ASSOCIATES, S.C. Eberle Medical Building, 800 Biesterfield road, Suite 510 Elk Grove Village, IL 60007 NAME Kuljeet Kaur Gill M.D. Nickname: Kelly Address: Suburban Lung Associates SC 800 Biesterfield Rd, Suite 510 Elk Grove Village IL 60007 Central DuPage Hospital 25 N Winfield Road Winfield IL 60190 Edward Hospital 801 S Washington St Naperville IL 60540 Board Certification Diplomate, American Board of Psychiatry and Neurology, 2004 (Certificate # 52753) Diplomate, American Board of Sleep Medicine, 2005 Diplomate, American Board of Clinical Neurophysiology, 2007 Positions and Appointments September 2007-Present October 2005 May 2006 May 2006- April 2007 Suburban Lung Associates & Chicago Sleep Group Cleveland Clinic Florida, Naples Associate Professor of Neurology Director of Sleep Disorders Center & Laboratory 6101 Pine Ridge Road Naples, FL 34119 (In May 2006 Cleveland Clinic sold hospital and changed entities to Physicians Regional Medical Center and Medical Surgical Specialists)
Director of Sleep Center & Laboratory 6101 Pine Ridge Road Naples, FL 34119 July 2004- June 2005 July 2000- June 2003 June 1999- June 2000 NIH Sponsored Research Fellow, Division of Sleep Medicine Northwestern Memorial Faculty Foundation Senior and Junior Resident Loyola University Medical Center Loyola University, Stritch School of Medicine Chicago, Illinois Junior Resident Department of Internal Medicine Loyola University Medical Center Maywood, Illinois Education Medical School Saba University College of Medicine Netherlands-Antilles- Basic Sciences Gardner, Massachusetts- Clinical Office Degree- MD 1995 Graduate School...Chicago Medical School North Chicago, Illinois Applied Physiology Department Degree- MS 1995 Graduate School Northwestern University Evanston, Illinois Biotechnology Department- Research College..Northwestern University Evanston, Illinois Communication Disorders and Sciences; Pre-Medical Studies Degree- B.S 1993 Professional Organizations 2003-Present American Medical Association
2000-Present 2003-present 2004-present American Academy of Neurology American Clinical Neurophysiology Society American Academy of Sleep Medicine Licensure 2003-present Medicine, State of Illinois License Number 036-108659 Medicine, State of Florida License Number 89031 Medicine, State of Washington License Number 45097 Medicine, State of Colorado License Number 44130 ABSTRACTS AND SCIENTIFIC PRESENTATIONS AT NATIONAL MEETINGS: Gill, K, Park, Y. Severity of Restless Legs Syndrome and Sensory Nerve Dysfunction. Associated Professional Sleep Societies, 2005. Abstract Sleep Volume 28 2005 I. PROJECTS AND RESEARCH Principle investigator for Medical Surgical Specialists Phase IV A randomized, double-blind placebo-controlled, parallel group clinical trial comparing placebo and pramiprexole (Miraprex) 0.25 mg administered orally to investigate the safety and efficacy in patients with idiopathic Restless Legs Syndrome for 6 weeks. Sponsor: Boehringer Ingelheim Sleep Medicine/ Clinical Neurophysiology Fellow: Exercise: A countermeasure for sleep loss in older adults (PI: Zee), NIH/NIA Program Project Grant, 1P01 AG 114112, Alterations of Sleep and Circadian Timing in Aging (E. VanCauter). Grant Proposal: National Multiple Sclerosis Society: Abnormal Nocturnal Ventilatory Control as Sequelae of Intrathecal Baclofen Treatment Principle Investigator: Severity of Restless Legs Syndrome and Sensory Nerve Dysfunction.
Case Series: Delayed Sleep Phase Syndrome presenting with Refractory Hypersomnia. A randomized, double-blind placebo-controlled, parallel group clinical trial comparing fixed doses of 0.25mg, 0.50 mg, and 0.75mg pramiprexole (Miraprex) administered orally to investigate the safety and efficacy in patients with idiopathic Restless Legs Syndrome for 12 weeks. Sponsor: Boehringer Ingelheim Evaluation of the long-term efficacy and safety of Zolpidem-MR 12.5mg compared to placebo, when both are administered over a long-term period as needed, in patients with chronic primary insomnia. (A randomized, doubleblind placebo-controlled, parallel group, multicenter, phase IIIb clinical study). Sponsor: Sanofi-Synthelabo Research, USA A randomized, double-blind placebo-controlled study to Assess the Subjective Response to Treatment with Ramelteon (TAK 375) in Adult Subjects with Chronic Insomnia by Utilizing an Interactive Voice Response System (IVRS) For Collecting Diary Data Sponsor: Takeda Global Research and Development A Phase II, double-blind, placebo-controlled, randomized, parallel-group, multicenter study to Evaluate the Efficacy and Safety of 40 mg/day KW-6002 (Istradefylline) in Subjects with Restless Legs Syndrome (RLS) Sponsor: Kyowa Pharmaceuticals, Inc. A multi-center, randomized, double-blind, placebo-controlled, five-arm parallel-group trial to investigate the efficacy and safety of four different transdermal doses of rotigotine in subjects with idiopathic Restless Legs Syndrome Sponsor: Schwarz Biosciences, Inc. Neurology Residency: Principle Investigator: Effects of NOGO-A Blockade on Dopaminergic Fiber Growth in the Adult Rat after Stroke. Principle Investigator: Utility of Nerve and Muscle Biopsy in Diagnosis of Vasculitic Neuropathy & Myopathy. Graduate Student: Posttranslational mutation of AUUUA sequence in rat neurons with diabetes mellitus. Language and cognitive dysfunction in autistic children.